journal article·2019-12-04Open access

Cancer cell membrane coated silica nanoparticles loaded with ICG for tumour specific photothermal therapy of osteosarcoma

Jingwei Zhang, Yu Miao, Weifeng Ni, Haijun Xiao, Jieyuan Zhang

Abstract

Photothermal therapy (PTT) is a rapidly developing approach for cancer therapy, which has been widely recognized to exert high efficacy as compared to chemotherapy. However, the limited tumour homing property of currently available drug delivery systems (DDSs) is the bottleneck for the efficient delivery of photothermal agents. Here in this study, we surface modified silica nanoparticles (SLN) with the cell membrane (CM) derived from 143B cells to construct a platform (CM/SLN) capable of targeting the homogenous 143B cells. In addition, indocyanine green (ICG) as a photothermal agent was encapsulated into CM/SLN to finally construct a DDS suitable for tumour-targeted PTT of osteosarcoma. Our results revealed that CM/SLN/ICG was mono-dispersed core-shell nanoparticles with advanced stability in a physiological environment. Moreover, due to the modification of CM, CM/SLN/ICG could specifically target the homogenous 143B cells both in vitro and in vivo, which demonstrated superior anticancer efficacy when compared with either SLN/ICG or free ICG. Hence, CM/SLN/ICG could be a promising DDS for tumour targeted PTT of osteosarcoma.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics, Shanghai Fengxian District Central Hospital / Shanghai University of Medicine & Health Sciences Affiliated Sixth People's Hospital South Campus

Department of Orthopedics, Shanghai Sixth People’s Hospital

Funding

National Natural Science Foundation of China

References (43)

Show source-provided references
1. 10.1166/jbn.2016.214910.1166/jbn.2016.2149 ↗
2. 10.1039/C8CC07694D10.1039/C8CC07694D ↗
3. 10.1039/C8BM00706C10.1039/C8BM00706C ↗
4. 10.1039/C6CC08146K10.1039/C6CC08146K ↗
5. 10.1002/adma.20170640710.1002/adma.201706407 ↗
6. 10.1016/j.colsurfb.2018.06.01710.1016/j.colsurfb.2018.06.017 ↗
7. 10.2147/IJN.S11749510.2147/IJN.S117495 ↗
8. 10.1080/10717544.2017.130947510.1080/10717544.2017.1309475 ↗
9. 10.1016/j.ejps.2015.12.01410.1016/j.ejps.2015.12.014 ↗
10. 10.1016/j.colsurfb.2017.01.01010.1016/j.colsurfb.2017.01.010 ↗
11. 10.1016/j.actbio.2015.11.03610.1016/j.actbio.2015.11.036 ↗
12. 10.1016/j.msec.2016.12.05610.1016/j.msec.2016.12.056 ↗
13. 10.1039/C7RA07796C10.1039/C7RA07796C ↗
14. 10.1039/C8BM00570B10.1039/C8BM00570B ↗
15. 10.1039/C7CC05894B10.1039/C7CC05894B ↗
16. 10.1016/j.actbio.2015.11.03110.1016/j.actbio.2015.11.031 ↗
17. 10.1080/10717544.2018.142577710.1080/10717544.2018.1425777 ↗
18. 10.1016/j.actbio.2016.02.01210.1016/j.actbio.2016.02.012 ↗
19. 10.1016/j.actbio.2017.01.03110.1016/j.actbio.2017.01.031 ↗
20. 10.1038/ncomms1319310.1038/ncomms13193 ↗
21. 10.2147/IJN.S12124910.2147/IJN.S121249 ↗
22. 10.1002/adma.20160248610.1002/adma.201602486 ↗
23. 10.1080/09205063.2017.129634710.1080/09205063.2017.1296347 ↗
24. 10.1039/C7RA06119F10.1039/C7RA06119F ↗
25. 10.1021/acsami.8b0536310.1021/acsami.8b05363 ↗
26. 10.1016/j.biomaterials.2017.02.04110.1016/j.biomaterials.2017.02.041 ↗
27. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
28. 10.1002/smll.20160062410.1002/smll.201600624 ↗
29. 10.2217/nnm-2017-010010.2217/nnm-2017-0100 ↗
30. 10.1016/j.jcis.2018.10.03910.1016/j.jcis.2018.10.039 ↗
31. 10.2147/IJN.S19397610.2147/IJN.S193976 ↗
32. 10.1038/nprot.2014.01610.1038/nprot.2014.016 ↗
33. Cao Y, Song J, Ge J, et al. MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7. Oncol Lett. 2018;15:453–458.
34. 10.1039/C6TB02826H10.1039/C6TB02826H ↗
35. 10.1016/j.actbio.2018.12.02010.1016/j.actbio.2018.12.020 ↗
36. 10.1080/10717544.2018.156440310.1080/10717544.2018.1564403 ↗
37. 10.1080/21691401.2018.150138010.1080/21691401.2018.1501380 ↗
38. 10.1002/mabi.20150029910.1002/mabi.201500299 ↗
39. 10.1021/nl500618u10.1021/nl500618u ↗
40. 10.1039/C6RA13822E10.1039/C6RA13822E ↗
41. 10.1039/C5RA26215A10.1039/C5RA26215A ↗
42. 10.1016/j.colsurfb.2016.09.03710.1016/j.colsurfb.2016.09.037 ↗
43. 10.1039/C4PY01135J10.1039/C4PY01135J ↗